endovision / Endovision.org

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
User-agent: * Allow: / # Optimization for Google Ads Bot User-agent: AdsBot-Google-Mobile User-agent: AdsBot-Google Disallow: /_api/* Disallow: /_partials* Disallow: /pro-gallery-webapp/v1/galleries/* # Block PetalBot User-agent: PetalBot Disallow: / Sitemap: https://www.endovision.org/sitemap.xml # Auto generated, go to SEO Tools > Robots.txt Editor to change

Meta Tags

Title	Endovision.org
Description	Endovision offers an alternative physician-driven pathway for device innovation through a Endovision offers an alternative physician-driven pathway for device innovation through a non-profit “incubator”
Keywords	Endovision, Ken, Kenneth, Binmoeller, IES, Interventional, Endoscopy, Services, CPMC

Server Information

WebSite	endovision.org
Host IP	185.230.63.186
Location	-

Related Websites

                        Site
                        Rank
                    

More to Explore

endovision.org Valuation

US$1,316,308

Last updated: 2023-05-16 10:36:48

endovision.org has Semrush global rank of 8,040,907. endovision.org has an estimated worth of US$ 1,316,308, based on its estimated Ads revenue. endovision.org receives approximately 151,882 unique visitors each day. Its web server is located in -, with IP address 185.230.63.186. According to SiteAdvisor, endovision.org is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$1,316,308
Daily Ads Revenue	US$1,216
Monthly Ads Revenue	US$36,452
Yearly Ads Revenue	US$437,419
Daily Unique Visitors	10,126
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
endovision.org.	A	3600	IP: 185.230.63.186
endovision.org.	A	3600	IP: 185.230.63.171
endovision.org.	A	3600	IP: 185.230.63.107
endovision.org.	NS	21600	NS Record: ns8.wixdns.net.
endovision.org.	NS	21600	NS Record: ns9.wixdns.net.
endovision.org.	MX	3600	MX Record: 20 endovision-org.mail.protection.outlook.com.
endovision.org.	TXT	3600	TXT Record: MS=ms82957642
endovision.org.	TXT	3600	TXT Record: v=spf1 include:spf.protection.outlook.com -all

HtmlToTextCheckTime:2023-05-16 10:36:48

top of page Endovision Foundation Publications Endovision Officers Mission Statements History of Endoscopy Frequent Asked Questions Mission Statements Mission Statements Donate Our mission: Promote and advance endoscopic technology to cure digestive tract disease and cancers. to About Why Endovision? Meet Endovision’s Founder Endovision offers an alternative physician-driven pathway for device innovation through a non-profit “incubator” model. Importantly, the non-profit model removes all potential conflicts-of-interest inherent to industry and investor-sponsored ventures. The goal is to provide endoscopists around the globe with an easily accessible, practical pathway to incubate "better way" ideas. Endovision is non-biased, which means the value of the idea is defined solely by the potential benefit to the patient. Prototypes are generated by Endovision’s engineers specialized in the gastrointestinal device space and tested in bench-top and animal models to establish

HTTP Headers

HTTP/1.1 301 Moved Permanently
Date: Sun, 23 Jan 2022 08:29:42 GMT
Content-Length: 0
Connection: keep-alive
location: https://www.endovision.org/
strict-transport-security: max-age=120
x-wix-request-id: 1642926582.5761685043542811624
Age: 0
Server-Timing: cache;desc=miss, varnish;desc=miss, dc;desc=84
X-Seen-By: yKskFaTI/RmB0yGOaMOo6Q==,sHU62EDOGnH2FBkJkG/Wx8EeXWsWdHrhlvbxtlynkVgjQgix2PZQleJWMrGkt0yr,m0j2EEknGIVUW/liY8BLLn3pJ6os+jMZl8eSiOUhV8yPfR5Gq0aOvPi6ADB6Ij8Q,2d58ifebGbosy5xc+FRalhFG59U1oRm4f/vezIIMwfvtbAVgJOXOcBPu0JwmXms0K1ofpz3/gHckv22ynR/1vA==,2UNV7KOq4oGjA5+PKsX47H+fZ7hxb3zTpeBcElOqbJhYgeUJqUXtid+86vZww+nL,2r0eby5dl6V4RsTzy6fSQLNWAONqCKBiM3v9n3f0nFJ9pAiCxHhredE3m8SaSeMp,LXlT8qjS5x6WBejJA3+gBQXCz7mVUgG7chQprR9C/fBNG+KuK+VIZfbNzHJu0vJu,mNYkRqsux5VmQ8IQhEXF2s41WSHvATyoraDRVtJkHpAchmbFLPVSqsqc86X3J5kgWIHlCalF7YnfvOr2cMPpyw==
Cache-Control: no-cache
X-Content-Type-Options: nosniff

HTTP/2 200 
date: Sun, 23 Jan 2022 08:29:43 GMT
content-type: text/html; charset=UTF-8
link: ; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,
x-wix-request-id: 1642926583.0311685020871008765
content-language: en
strict-transport-security: max-age=120
age: 0
set-cookie: ssr-caching=cache#desc=miss#varnish=miss#dc#desc=84; Max-Age=20; Expires=Sun, 23 Jan 2022 08:30:03 GMT
server-timing: cache;desc=miss, varnish;desc=miss, dc;desc=84
x-seen-by: wmgbEcS9zOENaefw7bU4YRpqwhxlqL36R/65fvcxohY=,qdrMdw4zrP0/E6B8JtgqKA==,sHU62EDOGnH2FBkJkG/Wx8EeXWsWdHrhlvbxtlynkVhrJ8ZwvNfbMTOkD0lgCM1M,m0j2EEknGIVUW/liY8BLLiqhbNx8IyWlPsD+XTdJuRQeGdLDLXwpLd0CTVHPbfOd,2d58ifebGbosy5xc+FRallBI+gk7k+TjYsZAWG6iuZqjNpi/sd08bFP+/0QosJ4PBi2H0vWISiyyb1ikVJxgOQ==,2UNV7KOq4oGjA5+PKsX47L/w64C2MEzM6m+Hxfbfe91YgeUJqUXtid+86vZww+nL,2+8df7/86SpxIBpm+VHpf7CmjBJuJG/5HfFYvtOgLYF9pAiCxHhredE3m8SaSeMp,LXlT8qjS5x6WBejJA3+gBVVD0rbuhI2xvHxuBaBPXgyTzRA6xkSHdTdM1EufzDIPWIHlCalF7YnfvOr2cMPpyw==,mNYkRqsux5VmQ8IQhEXF2jimPX98Xuy0t1jH9XyInhIDc1kmYW3JCgM60BOxfOwVVnd8Z4jLK9R467MyhrzM6w==,LXlT8qjS5x6WBejJA3+gBVVD0rbuhI2xvHxuBaBPXgyTzRA6xkSHdTdM1EufzDIPWIHlCalF7YnfvOr2cMPpyw==,LoUK8/saGAmOxZWtpubo2v604HuLKuj7PerTfretWmHEpL0NJHOnzLSyHUiICk3asbSbSIqlcOnd5GUQH9Z9gA==,vnnyTBxZ51OQwVc1vV5ZXM4TXRaCPDe3zYsT1HnxyO6TzRA6xkSHdTdM1EufzDIPWIHlCalF7YnfvOr2cMPpyw==,l7Ey5khejq81S7sxGe5Nk5dYOfR6IL+FbURXQ2SyjqeTzRA6xkSHdTdM1EufzDIPWIHlCalF7YnfvOr2cMPpyw==,/a5ccLSK1HEmwPNg/x6OukIT+c5HqyHveWvXmN7dchpNTh/Lbj6C57dtrSX9DdZ5FOjCqBfx7veX++bd/gpdO7lbZUcvHPG4de8+qRWPB58=
cache-control: no-cache
vary: Accept-Encoding
accept-ranges: bytes
x-content-type-options: nosniff
set-cookie: TS01e85bed=0141ccf4856aa1f027a96d451d8c72801b6708598ba230e9763fb0c4e45cd1c362a4506b80a73addbf10a9f76d33e0bf06be8e64e7; Path=/;SameSite=none;Secure
server: Pepyaka/1.15.10

endovision.org Whois Information

WHOIS LIMIT EXCEEDED - SEE WWW.PIR.ORG/WHOIS FOR DETAILS

endovision.org valuation and analysis